US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Newron Pharmaceuticals SPA

20.00

0.0000

Volume:- -

Turnover:- -

Market Cap:416.12M

PE:-25.69

High:20.00

Open:20.00

Low:20.00

Close:20.00

52wk High:20.00

52wk Low:9.36

Shares:20.81M

Float Shares:17.85M

Volume Ratio:1.46

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7786

EPS(LYR):-0.7749

ROE:-839.80%

ROA:-5.65%

PB:-32.59

PE(LYR):-25.81

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Newron Pharmaceuticals SPA

Exchange:

GREY

Establishment Date:

1999

Employees:

27

Office Location:

Via Antonio Meucci 3,Bresso,Milan,Italy

Website:

http://www.newron.com

Zip Code:

20091

Phone:

Fax:

39 02 610 34654

Introduction:

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its product pipeline comprises Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NWPHF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NWPHF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWPHF\",,,,,undefined,":{"symbol":"NWPHF","market":"US","secType":"STK","nameCN":"Newron Pharmaceuticals SPA","latestPrice":20,"timestamp":1781812800000,"preClose":20,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":17845300,"shares":20805797,"eps":-0.77865,"marketStatus":"Market Closed","change":0,"latestTime":"06-18 16:00:00 EDT Delay","open":20,"high":20,"low":20,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.77865,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"GREY","adjPreClose":20,"volumeRatio":1.4553291053861444},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWPHF\",,,,,undefined,":{"symbol":"NWPHF","floatShares":17845300,"roa":"-5.65%","roe":"-839.80%","lyrEps":-0.774921,"volumeRatio":1.4553291053861444,"shares":20805797,"dividePrice":0,"high":20,"amplitude":0,"preClose":20,"low":20,"week52Low":9.36,"pbRate":"-32.59","psRate":"18.98","week52High":20,"institutionHeld":0,"latestPrice":20,"eps":-0.77865,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.77865,"open":20,"prevYearClose":9.36,"prevWeekClose":20,"prevMonthClose":20,"prevQuarterClose":20,"fiveDayClose":20,"twentyDayClose":20,"sixtyDayClose":9.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NWPHF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-03-19","symbol":"NWPHF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1710820800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2022-12-20","symbol":"NWPHF","reason":null,"defaultRemindTime":1671546600000,"announcedDate":"2022-12-19","type":"delisting","dateTimestamp":1671512400000},{"date":"2022-09-15","symbol":"NWPHF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1663228800000,"name":null,"time":"Pre-Market","dateTimestamp":1663214400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NWPHF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NWPHF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1775102400000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1882829,"yearFounded":1999,"employeeNum":27,"address":"Via Antonio Meucci 3,Bresso,Milan,Italy","zipCode":"20091","officePhone":"39 02 610 3461","officeFax":"39 02 610 34654","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.newron.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.1591},{"period":"ytd","weight":-0.1591}],"description":"Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease. Its product pipeline comprises Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.","exchange":"GREY","name":"Newron Pharmaceuticals SPA","nameEN":"Newron Pharmaceuticals SPA"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NWPHF\",market:\"US\",,,undefined,":null}}